General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Oct-2024 21:40:38
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG241030OTHRGG9E
Submitted By (Co./ Ind. Name)
Akhilesh Nand - Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
30/10/2024 17:50:00
Description (Please provide a detailed description of the event in the box below)
Please find enclosed the press release titled Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr for the quarter ended September 30, 2024.

Attachments

SGX_Biocon Q2FY25.pdf
Total size =1267K